LOC388553 Activators
LOC388553 can engage a variety of cellular signaling pathways to modulate the protein's activity. Forskolin and IBMX, for example, lead to the elevation of intracellular cyclic AMP (cAMP) levels. Forskolin directly stimulates adenylate cyclase, boosting cAMP production, while IBMX inhibits phosphodiesterases, which usually break down cAMP. The increase in cAMP activates protein kinase A (PKA), which can phosphorylate LOC388553, leading to its activation. Similarly, dibutyryl-cAMP and 8-Br-cAMP, both cell-permeable analogs of cAMP, directly activate PKA, thereby promoting the phosphorylation and activation of LOC388553. Epinephrine also raises cAMP levels by binding to adrenergic receptors and initiating a G protein-coupled response that activates adenylate cyclase. This cascade results in PKA activation and subsequent phosphorylation of LOC388553.
PMA activates protein kinase C (PKC), which may phosphorylate LOC388553 if it is a substrate for this kinase. Anisomycin activates stress-activated protein kinases like JNK, which could also phosphorylate LOC388553. Phosphorylation status is a common regulatory mechanism for protein activity; thus, inhibitors of protein phosphatases such as okadaic acid and calyculin A can lead to the sustained activation of proteins like LOC388553 by preventing their dephosphorylation. ZnCl2 can interact with proteins that have zinc-binding domains, directly modulating their activity, which suggests that if LOC388553 has such domains, ZnCl2 could alter its activity. Lastly, spermine can influence the activity of various kinase enzymes and ion channels, and if LOC388553 is regulated by such mechanisms, spermine could enhance its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) inhibits phosphodiesterases, thus preventing the breakdown of cAMP and potentiating its action. This sustained increase in cAMP can enhance PKA activity, which in turn may phosphorylate and activate LOC388553. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA (CAS 16561-29-8) functions as an effective activator of LOC388553, modulating protein kinase C (PKC) pathways crucial in cell signaling studies. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, leading to G protein-coupled responses that increase cAMP levels, thereby activating PKA, which could phosphorylate and thus activate LOC388553 in a signaling cascade. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that can activate stress-activated protein kinases (SAPKs) like JNK. If LOC388553 activity is modulated by JNK phosphorylation, anisomycin could lead to its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which would prevent the dephosphorylation of proteins. If LOC388553 is regulated by phosphorylation, the inhibition of its dephosphorylation would result in its activation. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to okadaic acid, calyculin A inhibits protein phosphatases 1 and 2A, which could lead to the sustained activation of proteins by preventing dephosphorylation. This might activate LOC388553 if it is regulated via phosphorylation mechanisms. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cell-permeable cAMP analog that activates PKA. Activation of PKA can phosphorylate and potentially activate LOC388553 if it is a substrate for PKA. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cell-permeable cAMP analog that activates PKA. This can lead to the phosphorylation of downstream targets, potentially including LOC388553, resulting in its activation. | ||||||
Spermine | 71-44-3 | sc-212953A sc-212953 sc-212953B sc-212953C | 1 g 5 g 25 g 100 g | $61.00 $196.00 $277.00 $901.00 | 1 | |
Spermine can modulate the activity of various ion channels and kinase enzymes. If LOC388553 activity is dependent on such channels or kinases, spermine could enhance its activity by modulating the channel or kinase function. | ||||||